Differential Diagnosis of Urolithiasis: A Comprehensive Guide for Clinicians

Introduction

Urolithiasis, the formation of stones within the urinary tract, is a prevalent condition leading to numerous hospital visits. Often preventable through lifestyle modifications and managed with diverse treatment strategies, understanding urolithiasis is crucial for healthcare professionals. This article aims to provide a detailed overview of urolithiasis, emphasizing its differential diagnosis, etiology, management, and the vital roles of an interprofessional team in patient care.

Etiology of Urolithiasis

Kidney stones, or nephrolithiasis, originate in the kidneys. Urolithiasis occurs when these stones migrate from the renal pelvis into the urinary collecting system, including the ureters, bladder, and urethra. While many cases can be managed conservatively with pain relief and antiemetics, complications like obstruction, renal failure, or infection necessitate more aggressive interventions.¹

The majority (80%) of kidney stones are composed of calcium oxalate or phosphate. Less common types include uric acid (9%), struvite (10%), and cystine (1%) stones.² The type of stone is influenced by various risk factors such as diet, family history, environmental factors, medications, and underlying medical conditions.

Dietary risk factors significantly contribute to stone formation. These include inadequate fluid intake, high consumption of animal protein, high oxalate-rich foods (like beans, beer, berries, chocolate, nuts, tea, soda, spinach, and potatoes), and high salt intake.² Adequate hydration, aiming for approximately 2.5 liters of urine output daily, is recommended. Beneficial fluid choices include water, coffee, and low-sugar fruit juices (excluding tomato, grapefruit, and cranberry due to high sodium or oxalate content). Citrate consumption is protective against stone formation as it inhibits crystal aggregation by complexing with urinary calcium salts. Hypocitraturia is observed in 60% of calcium stone formers.³,⁴ Contrary to some beliefs, low calcium intake can paradoxically increase kidney stone risk. Reduced dietary calcium decreases calcium availability in the GI tract to bind with oxalate, leading to increased oxalate absorption and urinary excretion, thus raising stone risk. High vitamin C and fish oil intake are also linked to increased calcium stone formation.

Personal and family history of kidney stones markedly increase the risk of recurrence. Bariatric surgeries, such as Roux-en-Y gastric bypass and sleeve gastrectomy, are associated with a threefold increase in calcium oxalate stone formation due to malabsorption, resulting in elevated urinary oxalate, reduced urine volume, and decreased urine citrate.⁵

Certain medical conditions elevate kidney stone risk, including chronic kidney disease, hypertension, gout, diabetes mellitus, hyperlipidemia, obesity, endocrine disorders, and malignancies. Obesity, hyperlipidemia, and type 2 diabetes are strongly linked to calcium oxalate and uric acid stones. Patients with these conditions often have diets high in animal protein, salt, and sugar, predisposing them to stone formation. Insulin resistance in obesity and type 2 diabetes promotes metabolic changes that increase urinary calcium and uric acid excretion, fostering stone development. Studies have shown that increased BMI and adiposity are significant risk factors for symptomatic stone formation.⁶,⁷

Drug-induced urolithiasis is less frequent, accounting for about 2% of cases. Common culprits include protease inhibitors (atazanavir, indinavir) used in HIV treatment and sulfadiazine. Protease inhibitor stones are radiolucent on standard CT scans and have a gelatinous consistency, often making them resistant to lithotripsy and frequently causing significant urinary obstruction requiring ureteral stenting.⁸ Ceftriaxone is also associated with increased stone risk in long-term therapy.⁹

Struvite stones, or infection stones, are less common and can grow silently into large staghorn calculi, filling the renal collecting system. Composed of magnesium ammonium phosphate, they form in alkaline urine, typically due to urease-producing bacteria like Proteus or Klebsiella. Urease breaks down urea into ammonia, raising urinary pH (often above 8) and promoting struvite stone formation.¹⁰

Uric acid stone formation is linked to low urinary uric acid levels, low urine pH, and low urine volume. While often idiopathic, metabolic conditions like diabetes and obesity increase the risk. Low urinary pH (below 5.5) favors uric acid crystallization. Diets rich in animal proteins increase uric acid load and precipitation. Gout, certain cancers, and chronic diarrhea are also associated with uric acid stones.¹¹

Cystine stones are rare, resulting from a congenital disorder causing mutations in SLC3A1 and SLC7A9 genes. These mutations disrupt cystine metabolism and transport, leading to cystinuria and stone formation, often presenting in childhood or adolescence, and can also form staghorn calculi.¹²

Epidemiology of Urolithiasis

Urolithiasis is a widespread condition affecting approximately 1 in 11 individuals in the United States, incurring an estimated $5 billion in healthcare costs annually and accounting for about 1 million emergency department visits. Prevalence is increasing, particularly in the working-age population. Men are more commonly affected than women (10.6% vs. 7.1%). Obesity is a significant risk factor, equalizing kidney stone formation risk between men and women. While ethnic variations exist, studies indicate that non-Hispanic white males have the highest prevalence, followed by Hispanic and then non-Hispanic Black individuals. Women are more prone to struvite stones due to higher rates of urinary tract infections.

Recurrence rates are high, with up to 50% of individuals experiencing another symptomatic urolithiasis episode within five years of the initial event.¹³,¹⁴,¹

Pathophysiology of Urolithiasis

Urolithiasis develops when stone-forming crystals become supersaturated in urine due to high concentration. These crystals aggregate and crystallize within the kidney parenchyma, forming renal calculi. These calculi can enlarge and migrate into the ureter, becoming symptomatic. Obstruction by a stone prevents urine passage, leading to hydronephrosis due to upstream dilation of the ureter and renal pelvis. The ureteropelvic junction (UPJ), where the ureter is narrowest, is the most common obstruction site. Other narrow points are where the ureter crosses the iliac vessels and the ureterovesical junction (UVJ). Stone passage through the ureter is painful due to increased luminal tension and hydronephrosis, triggering prostaglandin release and causing the characteristic colicky pain.

Crystal nucleation and growth are central to kidney stone formation. Nucleation is the initial aggregation of crystals, driven by urine supersaturation with stone-forming materials.

Two main theories explain crystal growth and aggregation: free particle and fixed particle. The free particle mechanism suggests crystals grow and aggregate within the tubular urine, obstructing tubular openings and forming smaller stones. The fixed particle mechanism proposes stones form on Randall’s plaques, calcific deposits rooted in the basement membrane of the loop of Henle. The initial cause of Randall’s plaque formation remains unclear.¹⁵,¹⁶,¹⁷

History and Physical Examination in Urolithiasis

Patients with urolithiasis, regardless of stone type, often present with similar symptoms, ranging from asymptomatic to critically ill. Common presentations include sudden or gradual onset of unilateral colicky abdominal or flank pain that characteristically waxes and wanes. Hematuria (microscopic in about 90% of cases on urinalysis), nausea, vomiting, and potentially fever are also frequent.

Abdominal examination typically reveals a soft, non-distended abdomen. Pain location can vary depending on stone position: flank pain suggests UPJ involvement, while groin, scrotal, or labial pain may indicate a stone near the UVJ. Pediatric patients might present with irritability, inconsolable crying, fever, and vomiting. Acutely ill patients are often restless and unable to find a comfortable position due to severe pain.

In severe cases, urolithiasis can lead to urinary obstruction and sepsis. These patients exhibit more severe symptoms, including altered mental status ranging from mild confusion to obtundation due to metabolic derangements. Hemodynamic instability may be present in septic patients.

Evaluation of Urolithiasis

Initial evaluation of suspected urolithiasis involves appropriate laboratory tests:

• Urinalysis (UA) with microscopy: May reveal gross or microscopic hematuria, leukocyte esterase, nitrites, and white blood cells (WBCs).
• Urine HCG: For all women of reproductive age to rule out pregnancy.
• Complete Blood Count (CBC)
• Comprehensive Metabolic Panel (CMP)
• Lactic acid
• Lipase and Amylase: To rule out pancreatic etiologies in differential diagnosis.
• Blood cultures: If systemic inflammatory response syndrome (SIRS) criteria are met, suggesting possible sepsis.

Imaging modality selection depends on patient factors like body habitus, pregnancy status, cost, and radiation exposure concerns.

Renal ultrasound is ideal for initial imaging in pediatric and pregnant patients to avoid radiation exposure.¹⁸ It can identify stones in the kidneys, pyeloureteric and vesicoureteric junctions, and hydronephrosis from obstruction. Doppler ultrasound can assess urinary flow. Sensitivity for ureteric stones is 57%, and specificity is 97.5%. Stones appear echogenic (bright white) on ultrasound. Large body habitus and operator dependency can limit visualization and stone size assessment.

Kidney, ureter, and bladder X-ray (KUB) can detect radiopaque stones (calcium phosphate and oxalate) but not radiolucent stones (uric acid and cystine). Sensitivity is 45%, and specificity is 85%. KUB is less useful acutely but helpful for monitoring stone growth over time.

Non-contrast CT scan of the abdomen and pelvis is the preferred imaging for ureterolithiasis in non-pregnant adults if radiation is acceptable, with sensitivity and specificity of 95% and 98%, respectively. Stones smaller than 3 mm may be missed due to slice thickness. CT visualizes all stone types except those from HIV protease inhibitors. CT can also predict shock wave lithotripsy success; higher stone attenuation on CT suggests poorer response. Low-dose CT is generally not recommended for patients with a BMI over 30.

MRI is another option, with better sensitivity (82%) and specificity (98%) than ultrasound and KUB but inferior to CT. MRI reliably detects hydronephrosis, but stone visualization can be variable, relying on calcification detection and signal voids. MRI offers 3D imaging without radiation and is a good second-line option for pregnant and pediatric patients, adjunct to ultrasound. However, MRI is more expensive, time-consuming, and less readily available in emergency departments.¹⁹

The STONE score, a validated risk assessment tool, stratifies patients into low, moderate, or high probability of kidney stones based on sex, timing of pain onset, origin of pain, nausea, and erythrocytes (hematuria).²⁰

Treatment and Management of Urolithiasis

Urolithiasis treatment depends on the patient’s presentation, ranging from conservative medical therapy to surgical interventions. Initial management often focuses on pain control. Nonsteroidal anti-inflammatory drugs (NSAIDs) are first-line pain relievers, given orally or intravenously. Opioids are reserved for refractory pain. Intravenous lidocaine is also studied as an effective pain control option.²¹ Nausea and vomiting are managed with intravenous antiemetics like ondansetron, metoclopramide, or promethazine. Medical expulsive therapy (MET) with alpha-blockers like doxazosin and tamsulosin can aid passage of larger stones (5-10 mm) but is less effective for smaller stones. Intravenous fluids can be given for dehydration but do not directly facilitate stone passage.

Spontaneous stone passage occurs in approximately 86% of cases within 30-40 days.²²,²³,²² Stone size is a major determinant of passage time and likelihood:

1. ≤2 mm stones: Mean passage time 8 days, 87% passage rate.
2. 3 mm stones: Mean passage time 12 days, 76% passage rate.
3. 4-6 mm stones: Mean passage time 22 days, 60% passage rate.
4. 7 mm stones: 48% passage rate.
5. 8-9 mm stones: 25% passage rate.

Patients with small stones, stable bloodwork, no infection signs, and no acute obstruction can be managed with MET. Urgent urologic intervention is needed for patients with large stones, acute renal failure, oliguria/anuria, SIRS criteria, infection, or solitary kidney. Hospitalization may be necessary for intractable pain/vomiting, inability to tolerate oral intake, pregnancy, or pediatric patients for close observation.

Urologic interventions include extracorporeal shock wave lithotripsy (ESWL), flexible ureteroscopy (URS), and percutaneous nephrolithotomy (PCNL). Flexible URS is most common, involving endoscopic access through the lower urinary tract to visualize and retrieve the stone.²⁴ It is effective for lower pole stones (1.5-2 cm) and ideal for patients on anticoagulants/antiplatelets.²⁵

ESWL uses X-ray to target stones and shockwaves to fragment them for urine passage, potentially requiring ureteral stent placement. It is typically outpatient, requiring IV sedation or general anesthesia. Cystine stones may be ESWL-resistant.

PCNL is reserved for ESWL or URS failures or contraindications, preferred for stones >20 mm, staghorn calculi, and chronic kidney disease patients. Large kidney and proximal ureter stones are often treated with PCNL. It involves general or spinal anesthesia, a flank puncture, and ureteroscopic stone retrieval. Contraindications include pregnancy, bleeding disorders, and active urinary tract infections.²⁵

Acute renal obstruction with urinary tract infection is a urologic emergency, requiring emergent decompression via indwelling ureteral catheter or nephrostomy tube to prevent permanent renal damage and sepsis.

Long-term management for calcium urolithiasis includes thiazide diuretics, citrate salts (potassium citrate), and lifestyle changes.²⁶ Struvite stones often require surgical removal and urologic follow-up. Cystine stone management focuses on high fluid intake (3 liters/day urine output), low animal protein and sodium diet, potassium citrate, and thiol drugs. Uric acid stone prevention involves increased fruit and vegetable intake, reduced animal protein, potassium citrate, and uric acid-lowering medications like allopurinol.²⁷

Outpatient etiology testing includes serum (calcium, phosphorus, oxalate, sulfate, magnesium, citrate, cysteine, ammonium, vitamin D, lactate dehydrogenase, parathyroid hormone) and urine (electrolytes, pH, uric acid, creatinine, calcium) analyses to guide further management.²¹

Differential Diagnosis of Urolithiasis

Accurate differential diagnosis is crucial in patients presenting with symptoms suggestive of urolithiasis. While the STONE score aids in risk stratification, several other conditions can mimic urolithiasis and must be considered. The key to differential diagnosis lies in carefully evaluating the patient’s history, physical exam findings, and targeted investigations.

Conditions mimicking urolithiasis pain:

• Appendicitis: Right-sided flank or abdominal pain can be confused with ureteral colic. Appendicitis pain is typically more constant and localized to the right lower quadrant, often with rebound tenderness, guarding, and fever. CT scan can differentiate.
• Ovarian torsion: In women, especially with sudden onset lower abdominal or pelvic pain, ovarian torsion should be considered. Pain is often unilateral and severe. Pelvic ultrasound with Doppler can assess ovarian blood flow.
• Ectopic pregnancy: Ruptured ectopic pregnancy can cause severe abdominal and pelvic pain in women of reproductive age, along with vaginal bleeding and hemodynamic instability. Urine HCG and pelvic ultrasound are essential.
• Pelvic inflammatory disease (PID): Lower abdominal pain in women, often bilateral, associated with fever, vaginal discharge, and cervical motion tenderness. Pelvic exam and testing for sexually transmitted infections are crucial.
• Dysmenorrhea: Cyclic pelvic pain associated with menstruation, usually bilateral and crampy. History and pelvic exam are typically diagnostic.
• Musculoskeletal pain: Back or flank pain from muscle strain or vertebral issues can sometimes mimic renal colic, but lacks associated urinary symptoms. Physical exam and pain characteristics help differentiate.
• Herpes Zoster (Shingles): Pre-eruptive phase of shingles can cause radicular pain mimicking renal colic, especially if dermatomal distribution is not initially clear. Skin exam and history are key.
• Abdominal Aortic Aneurysm (AAA): Ruptured or expanding AAA can cause severe abdominal and back pain, potentially radiating to the flank. Pulsatile abdominal mass and hemodynamic instability are red flags. Abdominal CT is diagnostic.
• Mesenteric Ischemia: Severe abdominal pain out of proportion to physical findings, often with risk factors for vascular disease. CT angiography is needed for diagnosis.

Conditions mimicking urolithiasis urinary symptoms:

• Urinary Tract Infection (UTI) and Pyelonephritis: UTIs, especially pyelonephritis, can present with flank pain, dysuria, frequency, and hematuria, overlapping with urolithiasis symptoms. However, UTI pain is usually less colicky and more constant. Fever, CVA tenderness, and urinalysis showing pyuria and bacteriuria are suggestive of UTI. Pyelonephritis is typically associated with higher fever and systemic illness.
• Renal Abscess: Fever, flank pain, and systemic illness suggest renal abscess. CT scan is essential for diagnosis.
• Renal Artery Aneurysm rupture: Rare but can cause flank pain and hematuria. CT angiography can identify renal artery aneurysm.
• Lower Urinary Tract Infection (cystitis, urethritis): Primarily presents with dysuria, frequency, urgency, and suprapubic pain, less likely to cause flank pain unless ascending infection. Urinalysis is key to diagnosis.

Gastrointestinal conditions in the differential:

• Cholecystitis: Right upper quadrant pain, potentially radiating to the flank, can be confused with right renal colic. Cholecystitis pain is often associated with fatty food ingestion and may have Murphy’s sign on exam. Right upper quadrant ultrasound is diagnostic.
• Pancreatitis: Epigastric or upper abdominal pain radiating to the back, often with nausea and vomiting. Elevated lipase and amylase levels and abdominal CT are diagnostic.
• Diverticulitis: Left lower quadrant pain, fever, and change in bowel habits. CT scan of the abdomen and pelvis is diagnostic.
• Small Bowel Obstruction: Crampy abdominal pain, distention, vomiting, and obstipation. Abdominal X-rays or CT scan can confirm obstruction.
• Constipation: Can cause abdominal discomfort or pain, but typically lacks the acute, severe colicky nature of renal colic and associated urinary symptoms. History and physical exam usually differentiate.

A thorough history, including pain characteristics, associated symptoms, past medical history, and risk factors, combined with a focused physical examination and judicious use of laboratory and imaging studies, is essential for accurate differential diagnosis and appropriate management of patients presenting with suspected urolithiasis. Consideration of these differential diagnoses is vital to avoid misdiagnosis and ensure timely and appropriate patient care.

Prognosis of Urolithiasis

The prognosis for most patients with urolithiasis is excellent. Asymptomatic calyceal stones (non-struvite) generally do not require acute intervention and can be monitored with routine ultrasound or KUB. Stones smaller than 5-6 mm usually pass spontaneously and are managed medically with antiemetics, analgesia, increased fluids, and alpha-blockers like tamsulosin.²³ Patients with small stones should receive counseling on risk factor modification to prevent recurrence. Larger stones may require more invasive procedures like ESWL, PCNL, or URS, but patients generally have a good prognosis with appropriate management and risk factor modification. Infected stones also carry a good prognosis with prompt intervention, including antibiotics, hemodynamic stabilization, and stone removal.

Complications of Urolithiasis

Potential complications of urolithiasis include acute renal failure secondary to obstruction, anuria, urinary tract infection with renal obstruction, and sepsis.

Deterrence and Patient Education for Urolithiasis

Patient education is crucial for preventing urolithiasis recurrence. Key recommendations include maintaining adequate hydration (2.5-3.5 liters of fluids daily)²² and avoiding oxalate-rich foods for calcium stone formers. For expectant management, follow-up imaging and assessment are recommended after 14 days, along with NSAIDs for pain and urine straining to monitor for stone passage. A healthy lifestyle with weight loss if overweight/obese and a balanced, low-salt diet is encouraged. Limiting fish oil and vitamin C intake may reduce stone risk. Citric acid intake (lemon juice, orange juice, melon juice) is beneficial for stone prevention. Adequate calcium intake (milk, tofu, orange juice, almonds) can paradoxically reduce stone risk by binding oxalate in the gut, decreasing urinary oxalate excretion.²⁷

Enhancing Healthcare Team Outcomes in Urolithiasis

Effective management of urolithiasis requires seamless interprofessional communication, especially in the emergency department where most acute cases present. The clinical spectrum ranges from uncomplicated to critical illness. Prompt lab work, urinalysis, and imaging are essential for patients with more severe presentations. Nurses play a critical role in initial assessment, obtaining vital signs, and anticipating patient care needs. Pharmacists optimize medication dosing for antiemetics, analgesics, and antibiotics, especially in patients with renal dysfunction. Radiologists provide crucial detailed imaging reports on stone location, size, and obstruction. Effective communication between urologists, radiologists, and ED providers ensures optimal patient care and disposition. Intensivist consultation may be needed for critically ill patients requiring emergent surgery. In pediatric and pregnant patients, consultation with pediatric urologists and obstetricians is essential. An interprofessional approach with effective communication and timely specialist consultation improves outcomes for urolithiasis patients. For uncomplicated cases, prompt outpatient follow-up is vital for long-term management and recurrence prevention.

Review Questions

(Original article links to review questions here)

References

(Same as original article)

[1] Scales CD, Smith AC, Hanley JM, Saigal CS., Urologic Diseases in America Project. Prevalence of kidney stones in the United States. Eur Urol. 2012 Jul;62(1):160-5. [PMC free article: PMC3362665] [PubMed: 22498635]

[2] Chung MJ. Urolithiasis and nephrolithiasis. JAAPA. 2017 Sep;30(9):49-50. [PubMed: 28858017]

[3] Caudarella R, Vescini F. Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment. Arch Ital Urol Androl. 2009 Sep;81(3):182-7. [PubMed: 19911682]

[4] Curhan GC, Willett WC, Rimm EB, Stampfer MJ. Family history and risk of kidney stones. J Am Soc Nephrol. 1997 Oct;8(10):1568-73. [PubMed: 9335385]

[5] Espino-Grosso PM, Canales BK. Kidney Stones After Bariatric Surgery: Risk Assessment and Mitigation. Bariatr Surg Pract Patient Care. 2017 Mar 01;12(1):3-9. [PMC free article: PMC5361755] [PubMed: 28465866]

[6] Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA. 2005 Jan 26;293(4):455-62. [PubMed: 15671430]

[7] Aune D, Mahamat-Saleh Y, Norat T, Riboli E. Body fatness, diabetes, physical activity and risk of kidney stones: a systematic review and meta-analysis of cohort studies. Eur J Epidemiol. 2018 Nov;33(11):1033-1047. [PMC free article: PMC6208979] [PubMed: 30066054]

[8] Gentle DL, Stoller ML, Jarrett TW, Ward JF, Geib KS, Wood AF. Protease inhibitor-induced urolithiasis. Urology. 1997 Oct;50(4):508-11. [PubMed: 9338723]

[9] Izzedine H, Lescure FX, Bonnet F. HIV medication-based urolithiasis. Clin Kidney J. 2014 Apr;7(2):121-6. [PMC free article: PMC4377784] [PubMed: 25852859]

[10] Parkhomenko E, De Fazio A, Tran T, Thai J, Blum K, Gupta M. A Multi-Institutional Study of Struvite Stones: Patterns of Infection and Colonization. J Endourol. 2017 May;31(5):533-537. [PubMed: 28355093]

[11] Ma Q, Fang L, Su R, Ma L, Xie G, Cheng Y. Uric acid stones, clinical manifestations and therapeutic considerations. Postgrad Med J. 2018 Aug;94(1114):458-462. [PubMed: 30002092]

[12] Eggermann T, Venghaus A, Zerres K. Cystinuria: an inborn cause of urolithiasis. Orphanet J Rare Dis. 2012 Apr 05;7:19. [PMC free article: PMC3464901] [PubMed: 22480232]

[13] Khan SR, Pearle MS, Robertson WG, Gambaro G, Canales BK, Doizi S, Traxer O, Tiselius HG. Kidney stones. Nat Rev Dis Primers. 2016 Feb 25;2:16008. [PMC free article: PMC5685519] [PubMed: 27188687]

[14] Foster G, Stocks C, Borofsky MS. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs [Internet]. Agency for Healthcare Research and Quality (US); Rockville (MD): Jul, 2012. Emergency Department Visits and Hospital Admissions for Kidney Stone Disease, 2009. [PubMed: 23016164]

[15] Evan AP, Coe FL, Lingeman JE, Shao Y, Sommer AJ, Bledsoe SB, Anderson JC, Worcester EM. Mechanism of formation of human calcium oxalate renal stones on Randall’s plaque. Anat Rec (Hoboken). 2007 Oct;290(10):1315-23. [PubMed: 17724713]

[16] Evan AP, Lingeman JE, Coe FL, Parks JH, Bledsoe SB, Shao Y, Sommer AJ, Paterson RF, Kuo RL, Grynpas M. Randall’s plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest. 2003 Mar;111(5):607-16. [PMC free article: PMC151900] [PubMed: 12618515]

[17] Shadman A, Bastani B. Kidney Calculi: Pathophysiology and as a Systemic Disorder. Iran J Kidney Dis. 2017 May;11(3):180-191. [PubMed: 28575878]

[18] Semins MJ, Matlaga BR. Kidney stones during pregnancy. Nat Rev Urol. 2014 Mar;11(3):163-8. [PubMed: 24515090]

[19] Brisbane W, Bailey MR, Sorensen MD. An overview of kidney stone imaging techniques. Nat Rev Urol. 2016 Nov;13(11):654-662. [PMC free article: PMC5443345] [PubMed: 27578040]

[20] Moore CL, Daniels B, Gross CP, Luty S, Singh D. External Validation of the STONE Score. Ann Emerg Med. 2016 Feb;67(2):301-2. [PubMed: 26801385]

[21] Gottlieb M, Long B, Koyfman A. The evaluation and management of urolithiasis in the ED: A review of the literature. Am J Emerg Med. 2018 Apr;36(4):699-706. [PubMed: 29321112]

[22] Fontenelle LF, Sarti TD. Kidney Stones: Treatment and Prevention. Am Fam Physician. 2019 Apr 15;99(8):490-496. [PubMed: 30990297]

[23] Türk C, Petřík A, Sarica K, Seitz C, Skolarikos A, Straub M, Knoll T. EAU Guidelines on Diagnosis and Conservative Management of Urolithiasis. Eur Urol. 2016 Mar;69(3):468-74. [PubMed: 26318710]

[24] Rajamahanty S, Grasso M. Flexible ureteroscopy update: indications, instrumentation and technical advances. Indian J Urol. 2008 Oct;24(4):532-7. [PMC free article: PMC2684394] [PubMed: 19468513]

[25] Desai M, Sun Y, Buchholz N, Fuller A, Matsuda T, Matlaga B, Miller N, Bolton D, Alomar M, Ganpule A. Treatment selection for urolithiasis: percutaneous nephrolithomy, ureteroscopy, shock wave lithotripsy, and active monitoring. World J Urol. 2017 Sep;35(9):1395-1399. [PubMed: 28303335]

[26] Zisman AL. Effectiveness of Treatment Modalities on Kidney Stone Recurrence. Clin J Am Soc Nephrol. 2017 Oct 06;12(10):1699-1708. [PMC free article: PMC5628726] [PubMed: 28830863]

[27] Gul Z, Monga M. Medical and dietary therapy for kidney stone prevention. Korean J Urol. 2014 Dec;55(12):775-9.